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Objectives:  
To elucidate the differences in diagnosis of common chronic 
inflammatory skin (CIS) conditions (atopic dermatitis, psoriasis, 
alopecia areata, acne, vitiligo) among different ethnic groups and 
between dermatologic specialists and primary care providers. 
Figure 1. Clinic-Specific Effect (Psoriasis): 
Patients diagnosed with psoriasis in dermatology 
clinics are less likely to have rheumatoid arthritis, 
but more likely to have pneumonia, hypertension, 
Type 2 diabetes, type 1 diabetes, inflammatory 
bowel disease, chronic kidney disease, depression, 
anxiety, asthma, and osteoporosis. 
Figure 2. Ethnicity & Clinic Interaction Effect 
(Psoriasis): The interaction effects between clinic 
and ethnicity is not significant in most of the 
common comorbidities except for Type 2 diabetes 
and rheumatoid arthritis.
Methods:
● Data Retrieval: Utilized the DataDirect to obtain patient demographics, clinic sites of 
patient encounter, ICD9/10 codes issued for each encounter, and other clinical 
variables/comorbidities .
● Data Analysis: The primary response variable was whether the patients with CIS 
conditions have cormobid diagnosis or not. Thus,  the binary response variable is 
assumed to have only two values (one or zero).
Hypothesis:  There are discrepancies in CIS condition diagnosis among different ethnic groups in 
the specialized (i.e. dermatology) versus non-specialized (i.e. primary physician clinic) visits. 
Impact Statement: The downstream effects of this project will be to improve culturally-sensitive patient care, add to the existing literature regarding autoimmune comorbidities, and guide medical education. Because this 
study seeks to assess how diagnoses of CIS conditions vary based on the clinic setting and how they vary for different races, the data will be used to provide important guidance for improving education of non-dermatologic 
specialists for diagnosis of CIS, especially in skin of color. Furthermore, it will form the basis of future research utilizing the electronic health record system to determine quality of care for patients with chronic skin 
conditions, which includes rate of referral to a dermatology office when a CIS diagnosis is made in a primary care setting. 
